Market Cap 3.75B 998M 867M 810M 743M 1.4B 95.1B 1.43B 9.55B 3.74B 47.43B 3.66B 156B P/E 2026 *
16.8x
P/E 2027 * 15x
Enterprise Value 4.7B 1.25B 1.09B 1.01B 931M 1.76B 119B 1.79B 11.96B 4.69B 59.44B 4.59B 196B EV / Sales 2026 *
2.89x
EV / Sales 2027 * 2.4x
Free-Float
78.97%
Yield 2026 *
1.9%
Yield 2027 * 3.17%
1 day+1.29%
1 week+3.49%
Current month+0.32%
1 month+8.35%
6 months+8.50%
Current year+20.49%
1 week 29.86
Extreme 29.86
31.84
1 month 28.6
Extreme 28.6
31.84
Current year 24.96
Extreme 24.96
33.12
1 year 24.92
Extreme 24.92
33.12
3 years 20.94
Extreme 20.94
42.85
5 years 20.94
Extreme 20.94
57.9
10 years 20.94
Extreme 20.94
61.4
Manager TitleAgeSince
Chief Executive Officer 58 05/01/2021
Chief Executive Officer - 07/04/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 69 01/01/2019
Director/Board Member - 03/04/2016
Director/Board Member - 08/02/2020
Change 5-day change 1-year change 3-year change Capi.($)
+1.29%+3.49%+30.18%-20.71% 985M
-2.39%-6.36%+47.10%+149.66% 1,024B
-0.76%-4.34%+52.04%+49.09% 618B
-2.33%-4.60%+25.55%+64.44% 443B
+0.68%+0.25%+38.47%+31.95% 349B
-1.66%-1.89%+32.18%+37.17% 297B
-8.96%-9.23%+3.57%+3.64% 264B
-1.37%-5.71%-2.10%-44.43% 209B
-1.63%+0.69%+27.62%+64.23% 208B
+0.72%+0.48%+15.88%+73.64% 162B
Average -1.25%-0.98%+27.05%+40.87% 357.47B
Weighted average by Cap. -0.98%-2.16%+34.56%+70.31%

Financials

2026 *2027 *
Net sales 1.62B 433M 376M 351M 322M 608M 41.24B 618M 4.14B 1.62B 20.56B 1.59B 67.83B 1.92B 512M 445M 416M 382M 720M 48.84B 732M 4.9B 1.92B 24.36B 1.88B 80.33B
Net income 224M 59.77M 51.94M 48.5M 44.52M 83.95M 5.7B 85.41M 572M 224M 2.84B 220M 9.37B 253M 67.34M 58.52M 54.64M 50.16M 94.58M 6.42B 96.23M 644M 252M 3.2B 247M 10.56B
Net Debt 950M 253M 220M 205M 188M 355M 24.09B 361M 2.42B 947M 12.02B 928M 39.63B 863M 230M 200M 186M 171M 323M 21.9B 328M 2.2B 861M 10.92B 844M 36.01B
Logo Saudi Pharmaceutical Industries and Medical Appliances Corporation
Saudi Pharmaceutical Industries and Medical Appliances Corp SPIMACO ADDWAEIH SJSC is a Saudi Arabia based pharmaceutical company. The Company is primarily engaged in manufacturing of pharmaceutical products, medicines for human use and wholesale and retail of medicines and related products, development and marketing of medical and pharmaceutical products, research and development in medical science activities, operating and maintaining the healthcare facilities and any investments in related industries. The Company is organized into four segments which include Pharmaceutical Manufacturing, Trading and Distribution Services, Healthcare Services and Discontinued Operation. Products of the Company include tablets, capsules, syrups and suspensions, injections, creams, ointments and gels, suppositories, mouthwash and antiseptic products. The Subsidiaries of the Company include ARACOM Medical Company, Dammam Pharmaceutical Company, SPIMACO Misr Company for Distribution and others.
Employees
-
Date Price Change Volume
03/08/26 SAR 31.40 +1.29% 251,072
02/08/26 SAR 31.00 -0.96% 317,622
30/07/26 SAR 31.30 +3.71% 1,405,463
29/07/26 SAR 30.18 -1.18% 525,236
28/07/26 SAR 30.54 -0.26% 252,720
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
31.40SAR
Average target price
31.86SAR
Spread / Average Target
+1.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2070 Stock